Tag: NIH
-
Trial Shows Platelet Drug Benefit for Aplastic Anemia
A clinical trial has shown eltrombopag, a drug originally designed to stimulate production of platelets from bone marrow, can raise blood cell levels in some people with severe aplastic anemia, who have failed all standard therapies. The findings of the phase 2 trial conducted by the National Heart, Lung, and Blood Institute (NHLBI), and other…
-
Nanomaterials Registry Begun for Health, Environment Queries
RTI International in North Carolina has started the Nanomaterial Registry, a Web-based database and resource of biological and environmental information on materials developed through nanotechnology. The registry, available free to the public, is funded by three agencies of National Institutes of Health: National Institute of Biomedical Imaging and Bioengineering, National Institute of Environmental Health Sciences,…
-
Michigan Adds Six Embryonic Stem Cell Lines for Research
University of Michigan in Ann Arbor has added six new human embryonic stem cell lines to the national registry maintained by National Institutes of Health (NIH). The action makes a total of eight lines from the university available for federally-funded research. The university says the stem cells came from couples receiving treatments at Michigan’s Center…
-
Five More Pharma Companies Join NIH Drug Extension Project
A program at National Institutes of Health (NIH) to find new uses for currently tested drugs gained five more pharmaceutical company participants. Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Pharmaceutical (a division of Johnson & Johnson), and Sanofi will take part in the Discovering New Therapeutic Uses for Existing Molecules program, run by National Center for Advancing…
-
EPA/NIH Challenge Seeks Air Pollution, Physiology Sensor
Two federal agencies will award a total of $160,000 for sensors that can map air pollution concentrations, but also provide the physiological responses to those pollutants. The U.S. Environmental Protection Agency and National Institute of Environmental Health Sciences (NIEHS), part of National Institutes of Health, are sponsoring the My Air, My Health Challenge with InnoCentive,…
-
Genetic Tests Not Triggering More Health Care Use
Researchers at Group Health Research Institute in Seattle, National Institutes of Health, Henry Ford Hospital in Detroit, and Abt Associates in Bethesda, Maryland found patients who receive genetic tests for susceptibility to disease were no more likely to use medical services after receiving the results than before the tests. The study results appear online today…
-
NIH Grant Awarded for Smoking Relapse Prevention Drug
National Institute on Drug Abuse, part of the National Institutes of Health (NIH), has awarded Scripps Research Institute in Jupiter, Florida a grant to develop drugs that help prevent relapse in smokers who are kicking the habit. The five-year $8.4 million grant will support a team led by Scripps researcher Paul Kenny (pictured right). Scripps…
-
Three Drug Makers Partner with NIH to Expand Therapies
National Institutes of Health and three pharmaceutical manufacturers will collaborate on research to find new treatments for diseases from currently approved drugs. Pfizer, AstraZeneca, and Eli Lilly and Company will make at least 20 of their existing compounds available for this research to NIH’s National Center for Advancing Translational Sciences (NCATS). The program, called Discovering…
-
SBIR Grant Awarded for Infant Respiratory Vaccine
GenVec Inc. in Gaithersburg, Maryland received a Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases at National Institutes of Health to help fund development of the company’s vaccine against respiratory syncytial virus. The phase 1 SBIR grant is valued at some $590,000. Respiratory syncytial virus (RSV) infects…
-
NIH Funding Portfolio Evaluated With Investment Metrics
An interdisciplinary team of business, computer science, and medical researchers tested funding decisions at National Institutes of Health over a 42-year period using measures of investment efficiency from the world of finance. The findings of the team from Massachusetts Institute of Technology, Brigham and Women’s Hospital, and the investment management firm AlphaSimplex LLC in Cambridge,…